Virtual heart sheds new light on heart defect
(Medical Xpress)—A virtual heart, developed at The University of Manchester, is revealing new information about one of the world's most common heart conditions.
(Medical Xpress)—A virtual heart, developed at The University of Manchester, is revealing new information about one of the world's most common heart conditions.
The PRAGUE-12 trial is a randomized open multicenter study comparing cardiac surgery with MAZE versus cardiac surgery without MAZE in patients with coronary and/or valvular heart disease and with atrial fibrillation.
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison ...
Mitral regurgitation is a common heart valve disorder, where blood flows backwards through the mitral valve when the heart contracts and reduces the amount of blood that is pumped out to the body. It is a serious condition ...